Objectives: We report on the anesthesia subsection of a comprehensive nationwide survey (Canadian Electroconvulsive Therapy Survey/ Enquête canadienne sur les electrochocs) on the practice of electroconvulsive therapy (ECT) in Canada.
A fter implementation, in the 1940s, of muscle relaxation 1 and general anesthesia 2 to modify convulsive therapies for psychiatric disorders, clinical anesthesia practices and technologies have evolved substantially. According to current practices, the progression of events of an electroconvulsive therapy (ECT) treatment generally involves close time-sensitive collaboration between the ECT provider, the anesthesia provider, and the nurse and/or patient attendant to coordinate and provide the following: (1) pre-ECT patient preparation, (2) monitoring and recording of pretreatment physiological parameters, (3) preoxygenation, induction of anesthesia, and muscle relaxation, (4) postinduction ECT preparation (eg, protective positioning, deliberate hyperventilation, bite block insertion, administration of vasoactive drugs), (5) administration of the convulsive stimulus and monitoring of the seizure response, (6) monitoring and supporting the patient upon recovery from the seizure and the anesthetic, and (7) safe and timely discharge from the ECT suite. 3, 4 Thus, the main goals of anesthesia for ECT include cardiopulmonary stability, analgesia, and amnesia as well as prevention of neurological, cardiopulmonary, and traumatic complications without interfering with ECT efficacy. In view of the delay between innovations in anesthesia and ECT, and their implementation in practice, clinical surveys or ''audits'' serve to identify current gaps in knowledge translation. A Canadian group of investigators from psychiatry, anesthesiology, psychology, and nursing first convened to develop a descriptive nationwide survey 5 of ECT practices in Canada (Canadian Electroconvulsive Therapy Survey/Enquête canadienne sur les electrochocsV''CANECTS/ECANEC''), which was administered in 2007. This comprehensive survey, which is available from the authors, included 76 questions divided into 10 topic areas addressing issues regarding (1) treatment facilities, (2) patients and ECT treatments, (3) nursing, (4) anesthesia, (5) ECT equipment, (6) ECT stimulus characteristics, (7) ECT policies and procedures, (8) teaching, (9) budget, and (10) access to ECT. Given the volume of data ensuing from this large comprehensive survey as well as the divergent scope of the different topic areas, we present here, separately, the survey subsection dealing with anesthesia including pre-ECT anesthesiologist consultation; management of high-risk patients; credentials of personnel providing anesthesia; monitoring, airway, and resuscitation equipment; anesthetic induction, muscle relaxant, vasoactive and other perianesthetic drugs and practices; and postanesthetic discharge criteria.
MATERIALS AND METHODS
The University of British Columbia Research Ethics Board (UBC-REB) provided approval for the entire CANECTS survey (UBC-REB approval no. H05-80273, UBC Office of Research Services, Suite 102, 6190 Agronomy Rd, Vancouver, BC, V6T 1Z3). All registered (1273) Canadian health care institutions were contacted to determine which provided ECT, allowing us to identify the 175 Canadian institutions that provide ECT. We piloted the survey instrument at 14 sites for clarity of questions and English-French language equivalence and found the survey to have good face validity. Completion of various subsections of the survey by ECT team members most involved with that area ensured good accuracy of responses. After the development and testing of a pilot survey at 14 sites and subsequent revisions over the period from 2004 to 2006, the final version was sent to all 175 ECT-providing institutions in 2007, with late responses arriving as late as 2008. The purpose of the survey was to comprehensively describe various aspects of ECT provision in Canada, with the expectation that results would identify important clinical needs, treatment barriers, and other issues, the resolution of which might lead to improved patient care. As one part of this comprehensive ECT survey, 9 questions pertaining to anesthesia for ECT (Table 1) addressed pre-ECT anesthesiologist consultation; management of high-risk patients; credentials of personnel providing anesthesia; monitoring, airway, and resuscitation equipment; anesthetic induction, muscle relaxant, vasoactive and other perianesthetic drugs and practices; and postanesthetic discharge criteria. Survey results were reported using descriptive statistics. Selected survey question responses were cross-tabulated to describe variability in responses across teaching versus nonteaching sites, 4 levels of ECT treatment volumes (G100, 100Y299, 300Y599, and Q 600) and 3 different ECT treatment settings (operating room, g ECT is performed at an alternative, suitably equipped location within the same institution 4.7 At your institution, the following is/are usually given before or during ECT: (check all that apply) g Is delegated by the practitioner providing anesthesia to a nurse in the postanesthetic recovery area.
g Laryngoscopes g Is delegated by the practitioner providing the electrical stimulus to a nurse in the postanesthetic recovery area.
g Endotracheal tubes g Is decided based upon a specific numeric scoring system (specify): g Laryngeal mask airways g Other (specify): g Oropharyngeal airways g Difficult airway equipment (eg, gum elastic bougie, special laryngoscope blades, cricothyrotomy kit) postanesthetic care unit, and dedicated ECT suite, which is remote from an operating room and/or postanesthetic care unit).
RESULTS
Sixty-one percent (107/175) of the 175 ECT centers in Canada returned completed survey questionnaires. Quantitative summaries of survey responses to each of the 9 questions pertaining to anesthesia for ECT are shown in Figure 1 . Several questions allowed for more than one response so that survey item summaries do not always add up to 100%.
Pre-ECT Anesthesiology Consultation, Management of High-Risk Patients, and Credentials of Anesthesia Providers
More than 70% of respondents reported the completion of pre-ECT anesthesiology consultation for all (61%) or most (11%) patients. Cross tabulation of responses pertaining to pre-ECT anesthesiology consultation suggests comparable responses between teaching and nonteaching site but that sites providing 300 to 599 treatments per year (ie, second highest-volume sites) were less likely to provide consultations on all patients but more likely to selectively provide consultations in response to specific concerns (Fig. 2) . Only 2 sites reported never completing pre-ECT anesthesiology consultation. Patients with high anesthetic and/or ECT risks were treated as per usual routines at 67% of the sites because these sites were equipped to deal with high-risk patients. Alternative arrangements for patients with high anesthetic risks (ie, alternative treatment site or treatment exclusion) were reported by 33% of respondents. Cross tabulation of responses about highrisk patients suggests comparable responses between teaching and nonteaching sites and also comparable response across sites of varying treatment volumes (Fig. 2) . More than 90% of respondents reported that a Canadian Royal CollegeYcertified anesthesiologist (or equivalent) most commonly provided anesthesia for ECT. Eight sites reported that a general practitioner anesthetist and only one anesthesiology resident (supervised by an attending anesthesiologist) most commonly provided anesthesia for ECT.
Monitoring and Airway Equipment
Routine use of pulse oximetry was reported by all sites, but electrocardiogram and noninvasive blood pressure monitoring were reported as not being routinely used by 2 and one site, respectively. One of these sites indicated, however, that all monitors were immediately available. End-tidal capnography, thermometer, and peripheral nerve stimulator were reported as being routinely used by 21% (23/107), 20% (22/107), and 32% (34/107), respectively. All respondents reported having oxygen, laryngoscopes, and endotracheal tubes readily available within the ECT suite. The ready availability of a defibrillator, self-inflating ventilation bag (''Ambu bag'') and suction apparatus was disaffirmed by 5 sites, 3 sites, and one site, respectively. Availability of laryngeal masks, oropharyngeal airways, and difficult airway equipment was reported by 91% (96/105), 92% (97/105), and 85% (89/105), respectively. Although an external cardiac pacemaker was reported as being readily available by only 55% (58/105) of centers, it is likely that many defibrillators at reporting sites also have external pacing capability. Dantrolene and capnography were reported as readily available by only 65% (68/105) and 60% (63/ 105), respectively. Cross tabulation of responses about ready availability of dantrolene and capnography revealed comparable responses between teaching and nonteaching sites but trends of less frequent availability of dantrolene and capnography at nonoperating room ECT sites and lower-volume ECT sites (Fig. 2) .
Perianesthetic Drugs and Other Practices
Thiopental was reported as usually being used by 63% of the sites and propofol by 36% (note that the survey was first administered in 2007 before the Canada-wide shortage of thiopental). None of the responding sites reported providing ECT with no muscle relaxant. Succinylcholine was reported as usually being used by 93% (99/107) and rocuronium by 8% (9/107). Atropine and glycopyrrolate were reported as usually being used by 18% (19/107) and 19% (20/107), respectively. Clinically significant hemodynamic effects of ECT were reported as commonly being managed with esmolol, labetalol, metoprolol, hydralazine, nitroglycerin, and clonidine by 52% (54/103), 62% (64/103), 36% (37/103), 8% (8/103), 10% (10/103), and 8% (8/ 103), respectively (Fig. 1) . Sodium citrate was reported as being usually used by only 6 sites. All but 4 sites reported routinely using a bite block for ECT, but manual jaw support before and/or during ECT was reported as usually being used by only 77% (82/107). Preoxygenation before ECT was reported by 93% (100/107), but deliberate hyperventilation was reported by only 54% (58/107).
Postanesthesia Discharge
Discharge of ECT patients from the postanesthetic recovery area was reported as being the responsibility of the anesthesia provider and the ECT provider at 35% (37/107) and 7% (7/107) of the sites, respectively. Discharge of ECT discharge from the postanesthetic recovery area was reported as being delegated to a postanesthetic recovery nurse by the anesthesia provider and the ECT provider at 65% (70/107) and 21% (22/107) of the sites, respectively. Specific scoring criteria used for postanesthetic recovery area patient discharge were described by 21% (23/107) of the sites.
DISCUSSION
Overall, results from this section of the CANECTS/ ECANEC survey suggest perianesthetic practices for ECT in Canada that are largely consistent with Canadian Anesthesiologists' Society (CAS) practice guidelines. It should be noted, however, that we assessed practice patterns and that clinical outcomes were beyond the scope of this survey. At the present time, anesthesia for ECT in Canada is generally considered under the CAS practice guidelines. The observation that Canadian Royal CollegeYcertified anesthesiologists provide ECT care at more than 90% of the sites in this survey likely explains why most anesthesia monitoring and equipment patterns are uniformly adherent to CAS guidelines. 6 Also, muscle relaxant use by all sites and relatively frequent use of antihypertensive drugs suggest appropriate attention to seizure modification and hemodynamic stability during ECT. However, further attention must be paid to the relatively low proportion of the sites (60%Y65%) that reported readily available dantrolene and capnography in view of the potential, albeit rare, for unrecognized malignant hyperthermia 7 and the possible unanticipated need for endotracheal intubation 8 (in which capnography is considered the criterion standard for confirming proper positioning of the endotracheal tube) in the setting of ECT. This is particularly notable at nonYoperating room and low-volume ECT sites where availability of dantrolene and capnography was comparatively lower. It is also notable that only half of the survey respondents indicated routine deliberate hyperventilation before ECT. This may reflect some potential controversy regarding risk versus benefit of this intervention because some evidence suggests that hyperventilation may increase seizure duration 9 and reduce early post-ECT cognitive dysfunction 10 but, on the other hand, that hyperventilation may increase the risk of aspiration in individuals who are obese or pregnant.
11
The relatively low proportion of sites reporting readily available capnography could be due, in part, to CAS guidelines, 6 which, similar to the American Society of Anesthesiologists (http:// www.asahq.org), only consider capnography as ''required'' when endotracheal tubes or laryngeal mask airways are inserted. This raises the question of whether a more conservative monitoring approach requiring capnography for all patients undergoing general anesthesia for ECT should be adopted as has been recommended in Australia (http://www.anzca.edu.au) and the United Kingdom (http://www.aagbi.org).
The survey response rate of 61% may suggest some caution with respect to whether the survey responders are representative of all sites that provide ECT. This is actually a very good response rate in the context of a recently review body of organizational research survey literature. 12 A reassuring observation in this regard is that we found no statistically significant differences between responders and nonresponders with respect to catchment populations and institution size. 5 However, one limitation of the applicability of responses to the question about anesthetic induction drugs is that this survey was conducted several years after the severely decreased availability of methohexital 13 and immediately preceding the current shortage of thiopental that became apparent after completion of this survey.
14 This issue of drug availability is particularly relevant to the practice of ECT in light of evidence that seizure duration seems to be longer with methohexital (and perhaps also etomidate) compared to propofol and also that seizure duration (which may be proportional to ECT efficacy) can be prolonged by combining short-acting opioids such as remifentanil with reduced doses of anesthetic induction agents. 15 Thus, the practice of anesthesia for ECT is likely to fluctuate and adapt in response to the availability of optimal anesthetic induction agents. Whereas restricted availability to drugs like methohexital can sometimes be secured through governmental special access programs (eg, Health Canada Special Drug Access Program: http://www.hc-sc.gc.ca/dhp-mps/acces/ drugs-drogues/index-eng.php), more vigorous effort and collaboration with pharmaceutical manufacturers are needed to expand the pharmacological armamentarium for ECT. In addition to the need for improved availability of anesthetic drugs for ECT, data from other sections of this CANECTS survey (published elsewhere) have also demonstrated that restricted access to anesthesiologists' clinical services can often limit access to ECT. 5 Another potential limitation of this survey is that the generally singular responses recorded by the nominated survey respondent for each site does not necessarily capture the sometimes heterogeneous and diverse practices of several anesthesiologists within a group practice, particularly in larger centers. In fact, this raises a practical concern about challenges to the consistency of ECT practices when more than one anesthesia provider, and often more than one ECT provider, may be involved in one patient's ECT series.
In summary, results from this survey suggest reasonably widespread safe anesthetic practices for ECT across Canada. In comparing various details of anesthetic care, these data suggest a somewhat more cautious approach regarding varying aspects of practice than do patterns reported in recent surveys from Norway, 16 the UK, 17 Belgium, 18 and the Russian Federation. 19 For example, the use of a bite block was slightly less frequent in Norway, 16 electrocardiography and blood pressure monitoring were considerably less frequent in the UK, 17 and ECT unmodified with anesthesia or muscle relaxant was alarmingly prevalent in the Russian Federation. 19 Although the quality of anesthetic care in Canada reflected in the results of this survey is quite reassuring, it is important to note that the quantity, that is, availability of anesthesiologists, has been cited as a limitation to patients' access to ECT. 5 Finally, further improvements in anesthetic care of patients undergoing ECT may be facilitated by continued knowledge translation efforts and by gaining a better understanding of the management of high-risk patients.
